Treatment News : Interferon, High Blood Pressure May be Risk to Vision

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » August 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


August 22, 2012

Interferon, High Blood Pressure May be Risk to Vision

People living with hepatitis C virus (HCV) and who have high blood pressure should see an eye specialist while undergoing therapy with pegylated interferon-based regimens, concludes an Italian study published in the August issue of Hepatology. According to the research, which involved performing ophthalmologic examinations on 97 individuals being treated for HCV, retinopathy—a disease of the retina—was documented in nearly one-third (30.9 percent) of individuals participating in the study. The sight-threatening complication was most common among people with pre-existing eye problems and, notably, among those with high blood pressure. "Retinopathy is frequent during treatment with [pegylated interferon and ribavirin], especially in hypertensive patients, who may develop serious complications,” the authors conclude. “Screening for [pegylated interferon]-associated retinopathy should be recommended for HCV patients with hypertension.

To read the full journal article (paid subscription required), click here.

Search: interferon, hepatitis c, hcv, hypertension, blood pressure, retinopathy, retina, sight, vision

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.